Regeneron Pharmaceuticals (REGN) EPS (Diluted) Growth (5y) (2015 - 2026)
Regeneron Pharmaceuticals (REGN) EPS (Diluted) Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.72% |
| Dec 31, 2025 | -4.87% |
| Sep 30, 2025 | 13.00% |
| Jun 30, 2025 | 10.98% |
| Mar 31, 2025 | 6.03% |
| Dec 31, 2024 | 2.90% |
| Sep 30, 2024 | 14.50% |
| Jun 30, 2024 | 49.09% |
| Mar 31, 2024 | 9.46% |
| Dec 31, 2023 | 7.37% |
| Sep 30, 2023 | 11.45% |
| Jun 30, 2023 | 12.04% |
| Mar 31, 2023 | 11.51% |
| Dec 31, 2022 | 47.78% |
| Sep 30, 2022 | 28.58% |
| Jun 30, 2022 | 17.49% |
| Mar 31, 2022 | 31.82% |
| Dec 31, 2021 | 55.64% |
| Sep 30, 2021 | 44.51% |
| Jun 30, 2021 | 75.33% |